When Parvinder Singh died of cancer in 1999, Bhai Mohan Singh began to lobby for board positions for his grandchildren, Malvinder and Shivinder.
The two put out a statement that they would abide by their father's philosophy of segregating ownership from management, and were, therefore, not interested in any board position.
Things happened swiftly thereafter. Malvinder rose quickly within Ranbaxy and was soon on the board.
Then Brar decided to exit, and the road was clear for Malvinder.
Let's admit it - most Indian CEOs are very smart people.
Brar has set up a nice business of his own, and the business model is far less risky than Ranbaxy's.
Click NEXT to read more...

this
Users
Comment
article